About the Authors
- Melissa Dolan
-
Contributed equally to this work with: Melissa Dolan, Michalis Mastri
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliation Department of Experimental Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America
- Michalis Mastri
-
Contributed equally to this work with: Melissa Dolan, Michalis Mastri
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliation Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America
- Amanda Tracz
-
Roles Data curation, Methodology
Affiliation Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America
- James G. Christensen
-
Roles Resources
Affiliation Mirati Therapeutics, San Diego, California, United States of America
- Gurkamal Chatta
-
Roles Conceptualization, Methodology
Affiliation Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America
- John M. L. Ebos
-
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing
* E-mail: John.Ebos@RoswellPark.org
Affiliations Department of Experimental Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America, Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America
Competing Interests
JGC is a Mirati Therapeutics employee; JMLE received research support from Mirati Therapeutics. This does not alter our adherence to PLOS ONE policies on sharing data and materials.